Tuberculosis Drugs: Worldwide Market to Grow at 4.8% CAGR during 2018-2024 - Analysis by Disease Type, Drug Class and Region - ResearchAndMarkets.com

DUBLIN--()--The "Tuberculosis Drugs Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.

The report predicts the global tuberculosis (tb) drugs market to grow with a CAGR of 4.8% over the forecast period of 2018-2024. The study on tuberculosis (tb) drugs market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2016 to 2024.

The report on tuberculosis (tb) drugs market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global tuberculosis (tb) drugs market over the period of 2016 to 2024. Moreover, the report is collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global tuberculosis (tb) drugs market over the period of 2016 to 2024. Further, the Growth Matrix h Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.

Key Topics Covered

1. Preface

2. Executive Summary

3. Global Tuberculosis (TB) Drugs Market Overview

4. Global Tuberculosis (TB) Drugs Market by Disease Type

5. Global Tuberculosis (TB) Drugs Market by Drug Class

6. Global Tuberculosis (TB) Drugs Market by Region 2018-2024

7. Companies Covered

  • Pfizer
  • Otsuka Novel Products
  • Lupin
  • Sanofi
  • Novartis AG
  • Merck & Co.
  • Bayer AG
  • AstraZeneca
  • Sandoz International GmbH
  • Cipla Ltd.

For more information about this report visit https://www.researchandmarkets.com/research/pbsg2s/tuberculosis?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Respiratory Drugs, Infectious Diseases Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Respiratory Drugs, Infectious Diseases Drugs